Wave Life Sciences News: WVE Stock Slammed 54% by Duchenne Drug Failure

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Wave Life Sciences (WVE) news for Monday about it giving up on a Duchenne muscular dystrophy drug is hitting WVE stock hard.

The post Wave Life Sciences News: WVE Stock Slammed 54% by Duchenne Drug Failure appeared first on InvestorPlace.

• 2 Toxic Pot Stocks You Should Avoid
• 7 'A'-Rated Stocks to Buy Before 2020
• 7 of the Decade's Fastest-Growing Dividend Stocks
• 5 Cheap Dividend Stocks With High Yields And Annual Increases